Marcus Irsfeld
Founder at Artract Medical, Inc.
Marcus Irsfeld active positions
| Companies | Position | Start | End |
|---|---|---|---|
Artract Medical, Inc.
 Artract Medical, Inc. Medical SpecialtiesHealth Technology Artract Medical, Inc. is a medical device company based in New York, NY. The company has developed a passive hemodynamic assist device called the Artract System, which is implanted percutaneously to treat heart failure with preserved ejection fraction (HFPEF). HFPEF is a complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood. The Artract System reduces shortness of breath, improves exercise tolerance, and reduces the need for daily medication and frequent hospital stays. The company was founded by Marcus Irsfeld and Wolfgang Gœtz. | Director/Board Member | - | - |
| Founder | - | - |
Career history of Marcus Irsfeld
Former positions of Marcus Irsfeld
| Companies | Position | Start | End |
|---|---|---|---|
Trigen Holdings AG
 Trigen Holdings AG Miscellaneous Commercial ServicesCommercial Services Trigen Holdings AG develops drugs focusing on thrombosis and vascular dysfunction. Its product pipeline includes clinical stage candidates, TGN 255, TGN 167 and PR-15. The company has offices in London. Trigen Holdings was founded in 2005 and is headquartered in Martinsried, Germany. | Comptroller/Controller/Auditor | - | 2009-12-14 |
ProCorde GmbH
 ProCorde GmbH Miscellaneous Commercial ServicesCommercial Services Founded in 2000,Precorde GmbH develops biotechnology for the integrated development of biomedical drugs in cardiovascular diseases. | Director of Finance/CFO | 2001-06-30 | 2005-04-10 |
Training of Marcus Irsfeld
| University of Münster | Undergraduate Degree |
Statistics
International
| Germany | 4 |
| United States | 2 |
Operational
| Director of Finance/CFO | 1 |
| Comptroller/Controller/Auditor | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Commercial Services | 3 |
| Consumer Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
ProCorde GmbH
ProCorde GmbH Miscellaneous Commercial ServicesCommercial Services Founded in 2000,Precorde GmbH develops biotechnology for the integrated development of biomedical drugs in cardiovascular diseases. | Commercial Services |
Trigen Holdings AG
Trigen Holdings AG Miscellaneous Commercial ServicesCommercial Services Trigen Holdings AG develops drugs focusing on thrombosis and vascular dysfunction. Its product pipeline includes clinical stage candidates, TGN 255, TGN 167 and PR-15. The company has offices in London. Trigen Holdings was founded in 2005 and is headquartered in Martinsried, Germany. | Commercial Services |
Artract Medical, Inc.
Artract Medical, Inc. Medical SpecialtiesHealth Technology Artract Medical, Inc. is a medical device company based in New York, NY. The company has developed a passive hemodynamic assist device called the Artract System, which is implanted percutaneously to treat heart failure with preserved ejection fraction (HFPEF). HFPEF is a complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood. The Artract System reduces shortness of breath, improves exercise tolerance, and reduces the need for daily medication and frequent hospital stays. The company was founded by Marcus Irsfeld and Wolfgang Gœtz. | Health Technology |
- Stock Market
- Insiders
- Marcus Irsfeld
- Experience
